+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Imaging Agents Market by Agent Type, Modality, Application, End User, Distribution Channel - Global Forecast to 2030- Product Image
Imaging Agents Market by Agent Type, Modality, Application, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Imaging Agents Market by Agent Type, Modality, Application, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5888774
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Imaging Agents Market grew from USD 10.17 billion in 2024 to USD 10.76 billion in 2025. It is expected to continue growing at a CAGR of 5.67%, reaching USD 14.16 billion by 2030.

Setting the Scene for Imaging Agents Innovation

The realm of medical imaging agents has undergone a profound transformation, evolving from basic contrast enhancers to sophisticated molecular tracers that unlock unprecedented diagnostic clarity. This executive summary distills the critical developments reshaping the imaging agents market, defining the pivotal topics that industry leaders and decision-makers must understand. It weaves together the latest regulatory shifts, supply chain disruptions, segmentation dynamics, regional variations, competitive strategies, and actionable guidance to form a cohesive narrative. The aim is to present a concise yet thorough overview that illuminates the complexities and growth drivers defining this industry, empowering stakeholders to anticipate changes and capitalize on emerging opportunities.

By exploring the technological breakthroughs, policy initiatives, and strategic maneuvers of leading players, this document frames the imaging agents landscape within a global context. It highlights the ripple effects of tariff measures, the accelerating push toward precision diagnostics, and the intricate segmentation patterns that dictate product strategies. In addition, an examination of regional performance and market entry tactics underscores the geographic nuances that inform investment choices. Through an integrated approach, this introduction sets the stage for a deep dive into the evolving world of imaging agents.

Pivotal Transformations Reshaping Imaging Agents

Innovation in imaging agents has reached an inflection point, propelled by advancements in molecular biology, digital platforms, and regulatory harmonization. The integration of artificial intelligence and machine learning into image analysis pipelines has heightened demand for novel tracers that offer greater specificity and quantifiable metrics. Simultaneously, theranostic agents-capable of both diagnosing and delivering targeted therapy-have emerged from the research pipeline to clinical application, forging a new paradigm where diagnosis and treatment coalesce.

Regulatory bodies around the world have responded by accelerating approval pathways for breakthrough agents, fostering public-private collaborations and incentivizing orphan diagnostic programs. In parallel, the convergence of traditional modalities with hybrid systems-such as positron emission tomography combined with magnetic resonance imaging-has created a demand for dual-function contrast compounds optimized for multimodal detection. Overall, these transformative shifts are redrawing competitive boundaries and prompting organizations to reassess their R&D priorities, clinical trial designs, and partnership models.

Navigating the Impact of United States Tariffs 2025

The introduction of a new tariff framework in the United States has reverberated through global supply chains and pricing structures for imaging agents. Manufacturers reliant on imported raw materials have faced elevated procurement costs, necessitating renegotiation of supplier contracts and exploration of alternative sourcing strategies. In response, several producers have accelerated plans for localized manufacturing hubs, seeking to mitigate exposure to import levies and ensure continuity of supply for critical contrast agents and radiopharmaceutical precursors.

These adjustments have triggered downstream impacts on distributors and end users, with hospitals and diagnostic centers evaluating inventory strategies to balance cost pressures against clinical demand. At the same time, strategic alliances between domestic and international firms have gained traction as a means to share risk, co-develop next-generation compounds, and access broader market access pathways. The cumulative effect of these tariff measures is a reshaping of industry economics, compelling stakeholders to innovate across procurement, production, and pricing models.

Deep Dive into Market Segmentation Drivers

A nuanced understanding of market segmentation reveals the intricate drivers steering product development and commercialization efforts. When viewed through the lens of agent type, traditional gadolinium-based compounds remain foundational for magnetic resonance imaging, while iodinated contrast agents continue to dominate X-ray and computed tomography workflows. Microbubble formulations have expanded their footprint in ultrasound diagnostics, enabled by enhanced acoustic properties, and radiopharmaceuticals have bifurcated into PET imaging agents and SPECT imaging agents, each addressing unique clinical requirements and leveraging distinct isotopic characteristics.

Analyzing by imaging modality underscores divergent growth vectors. Computed tomography applications benefit from rapid scan speeds and widespread installation, while magnetic resonance imaging relies on superior soft-tissue contrast. Nuclear imaging platforms incorporate both PET imaging agents and SPECT imaging agents to fulfill functional and metabolic assessments, and ultrasound has evolved with two-dimensional and three-dimensional agent technologies that enrich anatomical visualization.

Application areas further refine the landscape, with cardiology leveraging perfusion tracers to guide interventional decisions, gastroenterology employing specialized agents for hepatic and pancreatic assessments, and musculoskeletal imaging adopting contrast-enhanced protocols for soft-tissue evaluation. Neurology continues to explore neuroreceptor binders for early detection of degenerative disorders, while oncology drives demand for tumor-targeting radiotracers that enable precise staging and treatment monitoring.

End users span academic research institutes pioneering early-stage trials, ambulatory surgical centers optimizing outpatient imaging workflows, diagnostic laboratories integrating multisite modalities, and hospitals alongside imaging centers that deliver comprehensive diagnostic services. Distribution pathways encompass direct sales channels that foster close customer relationships, distributors segmented into international and local networks to maximize reach, and online retail platforms that offer streamlined procurement for standardized contrast products.

Regional Dynamics Shaping Global Imaging Agents Markets

Regional variation shapes competitive positioning and investment strategies across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, robust healthcare infrastructure and favorable reimbursement mechanisms support rapid adoption of advanced imaging agents, with demand concentrated in major metropolitan hospitals and specialized centers. Regulatory clarity and strong intellectual property protection further entice global players to prioritize market launches and strategic partnerships in North America.

Across Europe Middle East & Africa, regulatory frameworks exhibit diverse timelines and requirements, prompting companies to engage in early dialogue with regional authorities and to establish localized trial networks. Investment in cross-border collaboration hubs has facilitated multicenter studies, while government initiatives targeting noncommunicable diseases have elevated the importance of diagnostic innovation in oncology and cardiology.

Asia-Pacific presents a dynamic growth frontier fueled by expanding hospital capacity, increased public health spending, and rising awareness of molecular imaging benefits. Rapid urbanization and the emergence of centers of excellence in countries across the region accelerate uptake of both established contrast agents and next-generation radiotracers. Strategic alliances and technology transfers underpin efforts to address price sensitivity while maintaining high standards of clinical performance.

Competitive Landscape and Key Players Driving Innovation

The competitive arena is characterized by a blend of established conglomerates and agile specialists driving the transition to precision diagnostics. Global healthcare technology leaders leverage extensive distribution networks and broad portfolios to cross-sell across modalities, while niche innovators focus on high-value applications such as theranostics and hybrid imaging agents. Strategic partnerships between equipment manufacturers and contrast suppliers have intensified, yielding co-developed solutions optimized for integrated scanner platforms.

Leading players have advanced their pipelines through targeted acquisitions and joint ventures that expand capabilities in radiopharmaceutical production, novel chelation chemistries, and microbubble engineering. Meanwhile, emerging enterprises emphasize first-in-class tracers addressing unmet clinical needs, deploying scalable manufacturing approaches to navigate regulatory complexity and accelerate time to market. These competing models underscore the importance of coordination between R&D, regulatory affairs, and commercial functions to secure sustainable differentiation.

Strategic Actions for Industry Leaders to Capitalize on Opportunities

To thrive amid evolving dynamics, industry leaders should prioritize the integration of cross-functional innovation strategies that span discovery, development, and delivery. Investing in next-generation molecular tracers tailored to high-impact applications such as oncology and neurology will unlock premium positioning within diagnostic pathways. Establishing flexible manufacturing networks in key geographies can mitigate tariff and supply chain risks, while fostering partnerships with contract manufacturing organizations ensures scalability and cost efficiency.

Furthermore, embedding digital health capabilities-such as agent tracking, usage analytics, and AI-driven decision support-will enhance value propositions and strengthen relationships with providers and payers. Engaging proactively with regulatory agencies to define clear approval frameworks and participating in collaborative consortia will accelerate access and reduce time to clinic. Finally, diversifying distribution channels through a balanced mix of direct sales, distributor alliances, and online platforms will optimize market coverage and respond to evolving procurement preferences among end users.

Rigorous Methodology Underpinning Our Research

Our research methodology combined exhaustive secondary research and primary stakeholder engagement to ensure rigor and reliability. We conducted a thorough review of peer-reviewed journals, regulatory filings, and patent databases to map the technological landscape. Complementing this, we engaged in structured interviews with executives, clinical specialists, distributors, and policymakers to capture nuanced perspectives on emerging challenges and growth catalysts.

Data triangulation techniques were applied to reconcile quantitative insights with qualitative inputs, reinforcing the validity of key findings. The analysis framework incorporated a multi-axis segmentation model, regional performance benchmarks, and competitive profiling to produce an integrated view of market dynamics. Finally, an internal peer review process validated the narrative coherence, methodological consistency, and actionable relevance of the report.

Concluding Perspectives on Imaging Agents Evolution

As imaging agents advance from conventional contrasts to precision tracers, the market landscape is being reshaped by technological breakthroughs, regulatory realignments, and strategic collaborations. The segmentation lens reveals distinct trajectories among agent types, modalities, applications, end users, and distribution pathways, each driven by unique clinical imperatives and commercial considerations.

Regional analysis highlights the interplay between infrastructure maturity, policy environments, and market access strategies, while the competitive overview underscores the dynamic tension between scale advantages and niche differentiation. By synthesizing these insights, decision-makers can chart a clear course through complexity, aligning R&D priorities, supply chain configurations, and go-to-market approaches with evolving clinical demands. In this context, the imaging agents sector stands poised for continued innovation, delivering enhanced diagnostic accuracy and therapeutic synergy.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Agent Type
    • Gadolinium Based Agents
    • Iodinated Contrast Agents
    • Microbubble Agents
    • Radiopharmaceuticals
      • Pet Imaging Agents
      • Spect Imaging Agents
  • Modality
    • Computed Tomography
    • Magnetic Resonance Imaging
    • Nuclear Imaging
      • Pet Imaging Agents
      • Spect Imaging Agents
    • Ultrasound Imaging
      • Three D Imaging Agents
      • Two D Imaging Agents
  • Application
    • Cardiology
    • Gastroenterology
    • Musculoskeletal
    • Neurology
    • Oncology
  • End User
    • Academic Research Institutes
    • Ambulatory Surgical Centers
    • Diagnostic Laboratories
    • Hospitals And Imaging Centers
  • Distribution Channel
    • Direct Sales
    • Distributors
      • International Distributors
      • Local Distributors
    • Online Retail
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • GE Healthcare
  • Bayer AG
  • Bracco Imaging S.p.A.
  • Guerbet S.A.
  • Lantheus Holdings, Inc.
  • Siemens Healthineers AG
  • Mallinckrodt plc
  • Fujifilm Holdings Corporation
  • Sagent Pharmaceuticals, Inc.
  • Cardinal Health, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Imaging Agents Market, by Agent Type
8.1. Introduction
8.2. Gadolinium Based Agents
8.3. Iodinated Contrast Agents
8.4. Microbubble Agents
8.5. Radiopharmaceuticals
8.5.1. Pet Imaging Agents
8.5.2. Spect Imaging Agents
9. Imaging Agents Market, by Modality
9.1. Introduction
9.2. Computed Tomography
9.3. Magnetic Resonance Imaging
9.4. Nuclear Imaging
9.4.1. Pet Imaging Agents
9.4.2. Spect Imaging Agents
9.5. Ultrasound Imaging
9.5.1. Three D Imaging Agents
9.5.2. Two D Imaging Agents
10. Imaging Agents Market, by Application
10.1. Introduction
10.2. Cardiology
10.3. Gastroenterology
10.4. Musculoskeletal
10.5. Neurology
10.6. Oncology
11. Imaging Agents Market, by End User
11.1. Introduction
11.2. Academic Research Institutes
11.3. Ambulatory Surgical Centers
11.4. Diagnostic Laboratories
11.5. Hospitals and Imaging Centers
12. Imaging Agents Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributors
12.3.1. International Distributors
12.3.2. Local Distributors
12.4. Online Retail
13. Americas Imaging Agents Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Imaging Agents Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Imaging Agents Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. GE Healthcare
16.3.2. Bayer AG
16.3.3. Bracco Imaging S.p.A.
16.3.4. Guerbet S.A.
16.3.5. Lantheus Holdings, Inc.
16.3.6. Siemens Healthineers AG
16.3.7. Mallinckrodt plc
16.3.8. Fujifilm Holdings Corporation
16.3.9. Sagent Pharmaceuticals, Inc.
16.3.10. Cardinal Health, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. IMAGING AGENTS MARKET MULTI-CURRENCY
FIGURE 2. IMAGING AGENTS MARKET MULTI-LANGUAGE
FIGURE 3. IMAGING AGENTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL IMAGING AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL IMAGING AGENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IMAGING AGENTS MARKET SIZE, BY MODALITY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IMAGING AGENTS MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL IMAGING AGENTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL IMAGING AGENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES IMAGING AGENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES IMAGING AGENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. IMAGING AGENTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. IMAGING AGENTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. IMAGING AGENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IMAGING AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IMAGING AGENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL IMAGING AGENTS MARKET SIZE, BY GADOLINIUM BASED AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL IMAGING AGENTS MARKET SIZE, BY IODINATED CONTRAST AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL IMAGING AGENTS MARKET SIZE, BY MICROBUBBLE AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL IMAGING AGENTS MARKET SIZE, BY PET IMAGING AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL IMAGING AGENTS MARKET SIZE, BY SPECT IMAGING AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL IMAGING AGENTS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL IMAGING AGENTS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL IMAGING AGENTS MARKET SIZE, BY PET IMAGING AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL IMAGING AGENTS MARKET SIZE, BY SPECT IMAGING AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL IMAGING AGENTS MARKET SIZE, BY THREE D IMAGING AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL IMAGING AGENTS MARKET SIZE, BY TWO D IMAGING AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL IMAGING AGENTS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL IMAGING AGENTS MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL IMAGING AGENTS MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL IMAGING AGENTS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL IMAGING AGENTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL IMAGING AGENTS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL IMAGING AGENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL IMAGING AGENTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL IMAGING AGENTS MARKET SIZE, BY HOSPITALS AND IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL IMAGING AGENTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL IMAGING AGENTS MARKET SIZE, BY INTERNATIONAL DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL IMAGING AGENTS MARKET SIZE, BY LOCAL DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL IMAGING AGENTS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES IMAGING AGENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 63. CANADA IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 64. CANADA IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 65. CANADA IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 66. CANADA IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 67. CANADA IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 68. CANADA IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. CANADA IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. CANADA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. CANADA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 72. MEXICO IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 73. MEXICO IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 74. MEXICO IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 75. MEXICO IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 76. MEXICO IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 77. MEXICO IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. MEXICO IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. MEXICO IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. MEXICO IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 118. GERMANY IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 119. GERMANY IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 120. GERMANY IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 121. GERMANY IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 122. GERMANY IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 123. GERMANY IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. GERMANY IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. GERMANY IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. GERMANY IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 127. FRANCE IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 128. FRANCE IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 129. FRANCE IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 130. FRANCE IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 131. FRANCE IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 132. FRANCE IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. FRANCE IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. FRANCE IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. FRANCE IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 136. RUSSIA IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 137. RUSSIA IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 138. RUSSIA IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 139. RUSSIA IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 140. RUSSIA IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 145. ITALY IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 146. ITALY IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 147. ITALY IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 148. ITALY IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 149. ITALY IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 150. ITALY IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. ITALY IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. ITALY IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. ITALY IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 154. SPAIN IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 155. SPAIN IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 156. SPAIN IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 157. SPAIN IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 158. SPAIN IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 159. SPAIN IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. SPAIN IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. SPAIN IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. SPAIN IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 163. UNITED ARAB EMIRATES IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 164. UNITED ARAB EMIRATES IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 167. UNITED ARAB EMIRATES IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 168. UNITED ARAB EMIRATES IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 172. SAUDI ARABIA IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 173. SAUDI ARABIA IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 174. SAUDI ARABIA IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 175. SAUDI ARABIA IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 176. SAUDI ARABIA IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 177. SAUDI ARABIA IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. SAUDI ARABIA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 186. SOUTH AFRICA IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. SOUTH AFRICA IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. SOUTH AFRICA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. SOUTH AFRICA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 190. DENMARK IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 191. DENMARK IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 192. DENMARK IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 193. DENMARK IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 194. DENMARK IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 195. DENMARK IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. DENMARK IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. DENMARK IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. DENMARK IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 208. QATAR IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 209. QATAR IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 210. QATAR IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 211. QATAR IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 212. QATAR IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 213. QATAR IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. QATAR IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. QATAR IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. QATAR IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 217. FINLAND IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 218. FINLAND IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 219. FINLAND IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 220. FINLAND IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 221. FINLAND IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 222. FINLAND IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. FINLAND IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. FINLAND IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. FINLAND IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 226. SWEDEN IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 227. SWEDEN IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 228. SWEDEN IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 229. SWEDEN IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 230. SWEDEN IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 231. SWEDEN IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. SWEDEN IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. SWEDEN IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. SWEDEN IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 244. EGYPT IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 245. EGYPT IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 246. EGYPT IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 247. EGYPT IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 248. EGYPT IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 249. EGYPT IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. EGYPT IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. EGYPT IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. EGYPT IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 253. TURKEY IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 254. TURKEY IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 255. TURKEY IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 256. TURKEY IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 257. TURKEY IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 258. TURKEY IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. TURKEY IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. TURKEY IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 261. TURKEY IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 262. ISRAEL IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 263. ISRAEL IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 264. ISRAEL IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 265. ISRAEL IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 266. ISRAEL IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 267. ISRAEL IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 270. ISRAEL IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 271. NORWAY IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 272. NORWAY IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 273. NORWAY IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 274. NORWAY IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 275. NORWAY IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 276. NORWAY IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. NORWAY IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. NORWAY IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 279. NORWAY IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 280. POLAND IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 281. POLAND IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 282. POLAND IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 283. POLAND IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 284. POLAND IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 285. POLAND IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. POLAND IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. POLAND IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 288. POLAND IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 289. SWITZERLAND IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 290. SWITZERLAND IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 291. SWITZERLAND IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 292. SWITZERLAND IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 293. SWITZERLAND IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 294. SWITZERLAND IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 295. SWITZERLAND IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 297. SWITZERLAND IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 298. ASIA-PACIFIC IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 299. ASIA-PACIFIC IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 300. ASIA-PACIFIC IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 303. ASIA-PACIFIC IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 304. ASIA-PACIFIC IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 305. ASIA-PACIFIC IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 306. ASIA-PACIFIC IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 307. ASIA-PACIFIC IMAGING AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 308. CHINA IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 309. CHINA IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 310. CHINA IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 311. CHINA IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 312. CHINA IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 313. CHINA IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 314. CHINA IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 315. CHINA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 316. CHINA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 317. INDIA IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 318. INDIA IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 319. INDIA IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 320. INDIA IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 321. INDIA IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 322. INDIA IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 323. INDIA IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 324. INDIA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 325. INDIA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 326. JAPAN IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 327. JAPAN IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 328. JAPAN IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 329. JAPAN IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 330. JAPAN IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 331. JAPAN IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 332. JAPAN IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 333. JAPAN IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 334. JAPAN IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 335. AUSTRALIA IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 336. AUSTRALIA IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 337. AUSTRALIA IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 338. AUSTRALIA IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 339. AUSTRALIA IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 340. AUSTRALIA IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 341. AUSTRALIA IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 342. AUSTRALIA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 343. AUSTRALIA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 344. SOUTH KOREA IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 345. SOUTH KOREA IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 346. SOUTH KOREA IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 347. SOUTH KOREA IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 348. SOUTH KOREA IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 349. SOUTH KOREA IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 350. SOUTH KOREA IMAGING AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 351. SOUTH KOREA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 352. SOUTH KOREA IMAGING AGENTS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 353. INDONESIA IMAGING AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2030 (USD MILLION)
TABLE 354. INDONESIA IMAGING AGENTS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 355. INDONESIA IMAGING AGENTS MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 356. INDONESIA IMAGING AGENTS MARKET SIZE, BY NUCLEAR IMAGING, 2018-2030 (USD MILLION)
TABLE 357. INDONESIA IMAGING AGENTS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 358. INDONESIA IMAGING AGENTS MARKET SIZE, BY APPLICATION, 2018-

Companies Mentioned

The companies profiled in this Imaging Agents market report include:
  • GE Healthcare
  • Bayer AG
  • Bracco Imaging S.p.A.
  • Guerbet S.A.
  • Lantheus Holdings, Inc.
  • Siemens Healthineers AG
  • Mallinckrodt plc
  • Fujifilm Holdings Corporation
  • Sagent Pharmaceuticals, Inc.
  • Cardinal Health, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 10.76 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.16 Billion
Compound Annual Growth Rate5.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Contrast Media Market by Product Type, Imaging Modality, Form, Route of Administration, Application, End User - Global Forecast to 2030 - Product Image

Contrast Media Market by Product Type, Imaging Modality, Form, Route of Administration, Application, End User - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global
From
MRI Contrast Media Agents Market by Product Type, Agent Class, Application, End Use, Distribution Channel, Administration Route - Global Forecast to 2030 - Product Image

MRI Contrast Media Agents Market by Product Type, Agent Class, Application, End Use, Distribution Channel, Administration Route - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Contrast Media - Global Strategic Business Report - Product Image

Contrast Media - Global Strategic Business Report

  • Report
  • 513 Pages
  • Global
From
Contrast Media Market: Analysis By Type, By Indication, By Route of Administration, By Procedure, By End User, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029 - Product Image

Contrast Media Market: Analysis By Type, By Indication, By Route of Administration, By Procedure, By End User, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029

  • Report
  • 184 Pages
  • Global
From
Imaging Agents Market By Product Type, By Application, By Modality, By Route of Administration, and By End-User, Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035 - Product Image

Imaging Agents Market By Product Type, By Application, By Modality, By Route of Administration, and By End-User, Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

  • Report
  • 210 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.